| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.39B | 155.96B | 140.73B | 126.70B | 110.12B | 109.65B |
| Gross Profit | 43.05B | 41.68B | 33.98B | 31.06B | 27.01B | 26.26B |
| EBITDA | 17.28B | 16.47B | 11.77B | 9.62B | 7.99B | 7.52B |
| Net Income | 11.39B | 11.19B | 7.00B | 5.23B | 4.72B | 4.79B |
Balance Sheet | ||||||
| Total Assets | 100.18B | 105.23B | 100.48B | 92.06B | 84.69B | 81.48B |
| Cash, Cash Equivalents and Short-Term Investments | 10.18B | 13.08B | 8.69B | 6.05B | 7.84B | 5.04B |
| Total Debt | 9.28B | 4.82B | 9.88B | 13.26B | 13.06B | 14.29B |
| Total Liabilities | 39.31B | 44.00B | 47.04B | 46.56B | 43.02B | 42.89B |
| Stockholders Equity | 60.87B | 61.23B | 53.44B | 45.49B | 41.67B | 38.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.61B | 8.53B | 454.00M | 9.41B | 4.41B |
| Operating Cash Flow | 0.00 | 13.88B | 9.94B | 4.76B | 11.01B | 5.24B |
| Investing Cash Flow | 0.00 | -1.10B | -437.00M | -5.03B | -5.13B | -2.27B |
| Financing Cash Flow | 0.00 | -8.41B | -6.02B | -2.65B | -3.30B | -3.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥165.31B | 9.64 | ― | 3.41% | 14.28% | 33.81% | |
78 Outperform | ¥691.94B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
70 Outperform | ¥84.01B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥168.22B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥140.85B | 11.45 | ― | 2.18% | -0.93% | -45.03% | |
55 Neutral | ¥29.86B | 3.47 | 0.31% | 1.75% | -14.20% | ― |